MC4R and diabetes mellitus: The interaction between dolutegravir (DTG) and melanocortin four receptor (MC4R) in vitro and binding of radiolabeled α melanocyte-stimulating hormone (MSH) to MC4R may explain weight gain, which is, in turn, a risk factor for the development of DM [21].